| HOME >> MEDICINE >> TECHNOLOGY |
CENTERVILLE, Mass., Feb. 21, 2012 /PRNewswire/ -- UV Flu Technologies, Inc. (OTCBB: UVFTD) (the "Company") is pleased to announce that in its 1st quarter report, filed on February 16, 2012, it continued to show the financial progress it has shown for the last 12 months, with another 20% reduction in liabilities in the latest quarter, along with significant increases in sales and gross profits. On February 3, 2012, the Company notified Asher Enterprises, LLC, that the remaining and final convertible note, in the amount of $32,500 would be paid off in cash, and those funds were wired Friday, February 17, 2011, paying the note off in full.
"We are continuing to expand our sales efforts, both domestically and internationally, to both the residential, and hospital markets," said Jack Lennon, President of UV Flu Technologies. "With respect to the Hospital market, two of our products were recently mentioned in an industry white-paper by Dr. Walter Kowalski, one of the world's authorities on ultra-violet light, in reference to the shortcomings of hospital HVAC systems with respect to infection control. The Viratech UV-400, and the RX-3000, air purifiers which give hospitals the ability to control infection at its source, were highlighted as highly effective in achieving this goal."
"Recent studies have shown direct links between indoor-air pollution and the risk of stroke, sleep disorders, respiratory issues including asthma and allergies, women's health issues and diabetes," said Mr. Lennon. "We believe there is no other more important factor in controlling individual health than purifying the 3500 to 4000 gallons of air that people breathe every day, and there is no bigger cost benefit to healthcare around the world. Air quality in many countries around the world is almost at toxic levels, which is why by year-end, we expect our products will be in distribution in India, China, Europe, Africa and Latin America, as well as the United States."<
'/>"/>
| SOURCE UV Flu Technologies, Inc. Copyright©2010 PR Newswire. All rights reserved |